Following the recent acceptance of our US cost-effectiveness manuscript, we are thrilled to share yet another milestone:

our Singapore cost-effectiveness study has been officially accepted as a late-breaking abstract at ASBMR 2025!✨

👉https://asbmr.confex.com/asbmr/2025/meetingapp.cgi/Paper/5488

📌 Presentation Details

Title: From X-Rays to Early Intervention: Cost-Effectiveness of Deep Learning-Powered Opportunistic Osteoporosis Screening in an Asian country

Presentation #: Sat-558

Session: Poster Session I: Late-Breaking Abstracts

Date/Time: Saturday, September 6, 2025 / 2:00–3:30 PM

This acceptance highlights the growing recognition of AI-based opportunistic screening as both clinically valuable and economically viable across diverse healthcare systems from the US to Asia.

📍 Meet us at Booth #315 at the Seattle Convention Center throughout ASBMR 2025 to learn more about our research and solutions.

🙏 Special thanks to Manju Chandran, Mickaël Hiligsmann, Jean-Yves REGINSTER 🌿and research partners for making this possible. We look forward to sharing more at ASBMR 2025 in Seattle!